Transseptal puncture for the treatment of structural heart disease: conventional needle or radiofrequency needle?

Courtesy of Dr. José Álvarez.

Transseptal Puncture for the Treatment of Structural Heart Disease: Conventional Needle or Radiofrequency Needle?This study sought to find differences in the transseptal puncture technique between the use of a conventional needle and the use of a radiofrequency-powered needle.

 

A total of 52 patients who underwent transseptal puncture for the treatment of various types of heart disease (Mitraclip, Watchman, Lariat, and mitral valvuloplasty) were retrospectively analyzed. A conventional needle was used in 25 cases (BRK, St Jude Medical) and a radiofrequency needle was used in the other 27 (Baylis Medical, Canada). All procedures included a transesophageal echocardiography; intended and actual puncture sites were analyzed in orthogonal views.

 

As a result, the puncture was effective in all cases in which a radiofrequency needle was used. As regards the conventional needle group, three patients required the use of an assistance wire to cross the septum and two patients had to be crossed over to the radiofrequency group. There were no differences as regards accuracy in the puncture site, but the time to septum crossing was lower for patients in the radiofrequency group. Septum tenting was higher in patients in the conventional needle group.

 

Editorial Comment

This is a retrospective observational study comparing two transseptal puncture techniques. Results were similar, except for a lower degree of septum tenting with a radiofrequency needle, which can be beneficial in cases in which the septum is lax and the conventional technique entails a risk of lesion to the left atrial lateral wall.

 

Courtesy of Dr. José Álvarez.

 

Original title: Accuracy and procedural characteristics of standard needle compared with radiofrequency needle transseptal puncture for structural heart interventions.

Authors: Gaufav Sharma MD, Gagan D Singh MD. Thomas Smith MD. Dali Fan MD, Reginald Low MD, Jason Rogers MD.

Reference: Cathet Cardiovasc Interv 2017; 89(6):E200-E206.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...

J-Valve for Chronic AR: 30-Day Outcomes of Transfemoral Valve J-Valve in Chronic Aortic Regurgitation

Chronic aortic regurgitation (AR) poses a significant challenge as far as transcatheter alternatives go due to the absence of calcification and a suitable anchoring...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...